OBJECTIVE: Opioid use is common for the management of postpartum pain. We sought to evaluate patient factors associated with time to first opioid dose following delivery. STUDY DESIGN: Retrospective case control study of all women who underwent delivery at a large tertiary care center (12/2015-16). Women were excluded if they had a nonsteroidal anti-inflammatory drug (NSAID) or morphine allergy. Inpatient records were queried for mode of delivery, patient characteristics, time-to-first opioid dose, and time-to-first NSAID dose after delivery. Time-to-first opioid was compared by patient characteristics with bivariable Cox regressions; these characteristics included age, BMI, self-described race/ethnicity, insurance, nulliparity, marital status, and history of anxiety, depression, smoking, and substance use. Factors which were significantly associated with time-to-use (p 0.05) on bivariable analysis were included in multivariable Cox regression models to identify factors independently associated with time-to-first opioid dose. Women who underwent vaginal delivery (VD) and cesarean delivery (CD) were analyzed separately. RESULTS: A total of 7,962 women who underwent VD and 2,831 women who underwent CD were included. In the final regression model for women who underwent VD, greater time-to-first NSAID dose (aHR 1.34, 95% CI 1.18-1.51), greater BMI (aHR 1.02, 95% CI 1.02-1.03), nulliparity (aHR 1.10, 95% CI 1.02-1.19), and a history of smoking (aHR 1.24, 95% CI 1.10-1.40) were significantly associated with earlier time-to-first opioid dose (Table) . In the final regression model for women undergoing CD, only history of smoking (aHR 1.19, 95% CI 1.05-1.35) and depression (aHR 1.15, 95% CI 1.02-1.30) were significantly associated with earlier time-tofirst opioid dose (Figure) . Conversely, nulliparity (aHR 0.85, 95% CI 0.79-0.92) and Asian race (aHR 0.84, 95% CI 0.72-0.98) were associated with a significantly greater time-to-first opioid dose for women who had CD. CONCLUSION: The time-to-first opioid dose following delivery is associated with patient characteristics. Notably, in women who underwent VD, a later first NSAID dose was significantly associated with a decreased time-to-first opioid dose. This finding suggests the potential importance of considering multimodal pain management strategies in postpartum women as a means of delaying opioid exposure.
